| scholarly article | Q13442814 |
| P2093 | author name string | Daniels R | |
| Elliot A | |||
| Gill D | |||
| Lambkin R | |||
| Oxford JS | |||
| Sefton A | |||
| P2860 | cites work | The structure and receptor binding properties of the 1918 influenza hemagglutinin | Q27643092 |
| Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus | Q27643093 | ||
| Characterization of the 1918 influenza virus polymerase genes | Q28275749 | ||
| Characterization of the reconstructed 1918 Spanish influenza pandemic virus | Q28275911 | ||
| Transmissibility of 1918 pandemic influenza | Q28298620 | ||
| 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. | Q30336398 | ||
| Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. | Q30471016 | ||
| Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial | Q31931976 | ||
| Oral oseltamivir treatment of influenza in children. | Q32064242 | ||
| Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study | Q39431184 | ||
| Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections | Q39437895 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study | Q42231038 | ||
| Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors | Q42541298 | ||
| Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. | Q43209129 | ||
| ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). | Q45153220 | ||
| PURULENT BRONCHITIS | Q64384555 | ||
| P433 | issue | 44-46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| influenza pandemic | Q2723958 | ||
| pandemic preparedness | Q88434121 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 6742-6746 | |
| P577 | publication date | 2006-06-16 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Scientific lessons from the first influenza pandemic of the 20th century. | |
| P478 | volume | 24 |
| Q41429903 | An influenza vaccine pill-can we swallow it? |
| Q30371219 | Deaths from bacterial pneumonia during 1918-19 influenza pandemic. |
| Q30226736 | Disease mongering and the fear of pandemic influenza |
| Q37706540 | Emergence of viral diseases: mathematical modeling as a tool for infection control, policy and decision making |
| Q27489882 | Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms |
| Q30228581 | Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia |
| Q30429787 | Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses |
| Q40529074 | Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model |
| Q57094327 | Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone |
| Q30372002 | Pandemic influenza forecasting: does past performance indicate future performance? |
| Q30404256 | Pandemic influenza: certain uncertainties |
| Q47227733 | Port d’Entrée for Respiratory Infections – Does the Influenza A Virus Pave the Way for Bacteria? |
| Q55447639 | The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. |
| Q37011494 | The human/animal interface: emergence and resurgence of zoonotic infectious diseases |
| Q30366265 | The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem? |
| Q30362060 | The threat of avian influenza H5N1: 'do we have the tools for the job'? |
| Q35921308 | Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses |
| Q43689050 | What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections |
| Q40454970 | [Emerging viral infectious diseases and pregnancy] |
Search more.